ArticleMolecular psychiatry2016
Response to Dr Fried & Dr Kievit, and Dr Malhi et al.
Abstract readComment
In one paragraph
Article in Molecular psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Systematic Evaluation of Machine Learning-Based Biomarkers for Major Depressive Disorder.JAMA psychiatry · 2024Article
- Lifetime Exposure to Depression and Neuroimaging Measures of Brain Structure and Function.JAMA network open · 2024Article
- Quantifying Deviations of Brain Structure and Function in Major Depressive Disorder Across Neuroimaging Modalities.JAMA psychiatry · 2022Article
Corrections and comments
- Comment on
- Comment on
- Comment on
Authors and funding
49 authors.
L SchmaalDepartment of Psychiatry and Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
D J VeltmanDepartment of Psychiatry and Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
T G M van ErpDepartment of Psychiatry and Human Behavior, University of California, Irvine, CA, USA.
P G SämannMax Planck Institute of Psychiatry, Neuroimaging Research Group, Munich, Germany.
T FrodlDepartment of Psychiatry and Psychotherapy, Otto von Guericke University of Magdeburg, Magdeburg, Germany.
N JahanshadImaging Genetics Center, Department of Neurology, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
E LoehrerDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MS, USA.
M W VernooijDepartment of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
W J NiessenDepartment of Radiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
M A IkramDepartment of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
K WittfeldGerman Center for Neurodegenerative Diseases (DZNE), Rostock/Greifswald, Germany.
H J GrabeGerman Center for Neurodegenerative Diseases (DZNE), Rostock/Greifswald, Germany.
A BlockDepartment of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
K HegenscheidInstitute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.
D HoehnMax Planck Institute of Psychiatry, Neuroimaging Research Group, Munich, Germany.
M CzischMax Planck Institute of Psychiatry, Neuroimaging Research Group, Munich, Germany.
J LagopoulosClinical Research Unit, Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia.
S N HattonClinical Research Unit, Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia.
I B HickieClinical Research Unit, Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia.
R Goya-MaldonadoCenter for Translational Research in Systems Neuroscience and Psychiatry, Department of Psychiatry and Psychotherapy, University Medical Center (UMG), Gerog-August-University, Goettingen, Germany.
B KrämerCenter for Translational Research in Systems Neuroscience and Psychiatry, Department of Psychiatry and Psychotherapy, University Medical Center (UMG), Gerog-August-University, Goettingen, Germany.
O GruberSection for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University Hospital, Heidelberg, Germany.
B Couvy-DuchesneQueensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.
M E RenteríaDepartment of Genetic Epidemiology, Queensland Institute of Medical Research Berghofer, Brisbane, QLD, Australia.
L T StrikeQueensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.
M J WrightQueensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.
G I de ZubicarayFaculty of Health, The Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Brisbane, QLD, Australia.
K L McMahonCenter for Advanced Imaging, The University of Queensland, Brisbane, QLD, Australia.
S E MedlandDepartment of Quantitative Genetics, Queensland Institute of Medical Research Berghofer, Brisbane, QLD, Australia.
N A GillespieVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA, USA.
G B HallDepartment of Psychology, Neuroscience and Behaviour, McMaster University, Hamilton, ON, Canada.
L S van VelzenDepartment of Psychiatry and Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
M-J van TolUniversity of Groningen, University Medical Center Groningen, Department of Neuroscience, Neuroimaging Center, Groningen, The Netherlands.
N J van der WeeDepartment of Psychiatry, Leiden University Medical Center, Leiden University, Leiden, The Netherlands.
I M VeerDivision of Mind and Brain Research, Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Berlin, Germany.
H WalterDivision of Mind and Brain Research, Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Berlin, Germany.
E SchrammDepartment of Psychiatry and Psychotherapy, University Medical Center Freiburg, Freiburg, Germany.
C NormannDepartment of Psychiatry and Psychotherapy, University Medical Center Freiburg, Freiburg, Germany.
D SchoepfDepartment of Psychiatry, University of Bonn, Bonn, Germany.
C KonradDepartment of Psychiatry and Psychotherapy, Agaplesion Diakoniklinikum, Rotenburg, Germany.
B ZurowskiCenter for Integrative Psychiatry, University of Lübeck, Lübeck, Germany.
A M McIntoshDivision of Psychiatry, University of Edinburgh, UK.
H C WhalleyDivision of Psychiatry, University of Edinburgh, UK.
J E SussmannDivision of Psychiatry, University of Edinburgh, UK.
B R GodlewskaDepartment of Psychiatry, Warneford Hospital, Oxford, UK.
F H FischerDepartment of Psychosomatic Medicine, Center for Internal Medicine and Dermatology, Charité Universitätsmedizin, Berlin, Germany.
B W J H PenninxDepartment of Psychiatry and Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
P M ThompsonImaging Genetics Center, Department of Neurology, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
D P HibarImaging Genetics Center, Department of Neurology, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
Funding
Training U54EB020403 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2014 to 2018
$10.1MMedical Research Council MR/K026992/1NIBIB NIH HHS U54 EB020403Wellcome Trust 104036
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.